Helena Hupková

Amoxicillin for acute lower-respiratory-tract infection in primary care when pneumonia is not suspected: a 12-country, randomised, placebo-controlled trial

Paul Little, Beth Stuart, Michael Moore et al. · The Lancet Infectious Diseases · 2012 · 226 citations · Full text

Susceptibilities to Telithromycin and Six Other Agents and Prevalence of Macrolide Resistance Due to L4 Ribosomal Protein Mutation among 992 Pneumococci from 10 Central and Eastern European Countries

Kensuke Nagai, Peter C. Appelbaum, Todd A. Davies et al. · Antimicrobial Agents and Chemotherapy · 2002 · 81 citations · Full text

Penicillin G-intermediate, Antimicrobial Chemotherapy, Antibiotic Resistance +21

Activity of telithromycin compared with seven other agents against 1039 Streptococcus pyogenes pediatric isolates from ten centers in central and eastern Europe

Bülent Bozdoğan, Peter C. Appelbaum, Linda M. Kelly et al. · Clinical Microbiology and Infection · 2003 · 49 citations

Eastern Europe, Antimicrobial Susceptibility, Antibiotics +10

Impact of amoxicillin therapy on resistance selection in patients with community-acquired lower respiratory tract infections: a randomized, placebo-controlled study

Surbhi Malhotra‐Kumar, Liesbet Van Heirstraeten, Samuel Coenen et al. · Journal of Antimicrobial Chemotherapy · 2016 · 43 citations · Full text

Susceptibility to Telithromycin in 1,011 <i>Streptococcus pyogenes</i> Isolates from 10 Central and Eastern European Countries

Kensuke Nagai, Peter C. Appelbaum, Todd A. Davies et al. · Antimicrobial Agents and Chemotherapy · 2002 · 42 citations · Full text